Skip to content

The effects of prophylactic norepinephrine Infusion on postoperative neurocognitive disorders in elderly hypertensive patients undergoing hip replacement with spinal anesthesia

The effects of prophylactic norepinephrine Infusion on postoperative neurocognitive disorders in elderly hypertensive patients undergoing hip replacement with spinal anesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090110
Enrollment
Unknown
Registered
2024-09-24
Start date
2024-09-25
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative neurocognitive disorders

Interventions

Control group:No intervention
Prophylactic norepinephrine Infusion group(N group):Noradrenaline was infused immediately after aspinal anesthesia at a rate of 0.01 ug / kg/min, adjusted within the range of 0-0.1ug/kg/min, and blood

Sponsors

Jiangsu Subei People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) ASA grade I-III; (2) Patients with indications for hip replacement surgery; (3) Age=65 years old, with no limit on gender; (4) Body mass index (BMI) of 18-24 kg/m^2; (5) Normal communication can be conducted (6)Hypertension I-II

Exclusion criteria

Exclusion criteria: (1) Simple Mental State Scale (MMSE) score: =180mmHg and/or DBP>=110mmHg) and secondary hypertension.

Design outcomes

Primary

MeasureTime frame
The incidence of POD;Incidence of neurocognitive disorders within 90 days after surgery;

Secondary

MeasureTime frame
The incidence of hypotension;Hospital complications (including reactive hypertension, bradycardia, nausea and vomiting,);Complications within 90 days (cardiovascular and cerebrovascular accidents, renal impairment, etc.);postoperative fatigue syndrome;Postoperative pain;Length of hospitalization;rS02 ;The Tau protein;

Countries

China

Contacts

Public ContactYali Ge

Jiangsu Subei People's Hospital

zyc17305141216@163.com+86 180 8235 2590

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026